Investigating a new type of fat cell involved in obesity.
Characterization and functional assessment of a novel population of Wnt/beta-catenin driven adopocytes.
This study is looking at a special type of fat cell that might help us understand how our bodies manage energy and why some people gain weight, with the hope that this could lead to better treatments for obesity and related health issues.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tulane University of Louisiana NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project ID | NIH-10812403 on NIH RePORTER |
What this research studies
This research focuses on understanding a novel population of fat cells, known as Wnt+ adipocytes, which are influenced by Wnt/β-catenin signaling. The study aims to explore how these cells contribute to energy balance and obesity-related metabolic disorders. By examining the differentiation and function of these adipocytes in various fat depots, including bone marrow, the research seeks to fill critical knowledge gaps regarding fat cell biology. Patients may benefit from insights that could lead to new treatments for obesity and its associated health risks.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are affected by obesity or related metabolic disorders.
Not a fit: Patients who are not affected by obesity or do not have related metabolic conditions may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for managing obesity and related metabolic diseases.
How similar studies have performed: While some studies have explored the role of Wnt signaling in fat cell biology, the investigation of Wnt+ adipocytes is a novel approach that has not been extensively tested.
Where this research is happening
New Orleans, United States
- Tulane University of Louisiana — New Orleans, United States (Active)
Researchers
- Principal investigator: Chen, Yiping — Tulane University of Louisiana
- Study coordinator: Chen, Yiping
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.